WJNS  Vol.3 No.4 , November 2013
The effect of picroside II on the expressions of AQP4, MMP9 and COX2 in cerebral ischemic injury in rats

The aim is to study the neuroprotective effect and optimize the therapeutic dose and time window of picrosede II by orthogonal test in cerebral ischemic injury in rats. The forebrain ischemia models of rats were established by bilateral common carotid artery occlusion (BCCAO) methods. The successful models were randomly grouped according to orthogonal experimental design and treated by injecting picroside II intraperitonenally with different therapeutic dose at different ischemic time. The contents of aquaporins 4 (AQP4), matrix metalloproteinases 9 (MMP 9) and cyclooxygenase 2 (COX2) in brain tissue were determined by enzyme linked immunosorbent assay to evaluate the therapeutic effect of picroside II on cerebral ischemic injury. The results indicated that the best therapeutic time window and dose of picroside II in cerebral ischemic injury should be 1) ischemia 1.5 h with 20 mg/kg body weight according to the content of AQP4; 2) ischemia 2.0 h with 20 mg/kg according to the content of MMP9; and 3) ischemia 1.5 h with 20 mg/kg according to the content of COX2 inbrain tissue. It is concluded that the optimized therapeutic dose and time window is injecting picroside II peritonenally with 10 - 20 mg/kg body weight at ischemia 1.5 - 2.0 h in cerebral ischemic injury according to the principle of lowest therapeutic dose with longest time window. 

Cite this paper
Li, X. , Li, Z. , Wang, T. , Zhang, M. and Pei, H. (2013) The effect of picroside II on the expressions of AQP4, MMP9 and COX2 in cerebral ischemic injury in rats. World Journal of Neuroscience, 3, 228-233. doi: 10.4236/wjns.2013.34030.
[1]   Zelenina, M. (2010) Regulation of brain aquaporins. Neurochemistry International, 57, 468-488. http://dx.doi.org/10.1016/j.neuint.2010.03.022

[2]   Sun, W., Su, Z.Q., Liu, J.F., Sheng, L., Yang, K.P. and Zhao, J.L. (2009) The effect of Kir4.1 and AQP4 in focal cerebral ischemia reperfusion injury rats. Chinese Journal of NeuroMed, 8, 484-487. http://dx.doi.org/10.3760/cma.j.issn.1671-8925.2009.05.013

[3]   Li, Z., Xu, X.Y., Li, Q., Zhang, M.Z. and Shen, W. (2010) Protective mechanisms of picroside on AQP4 in rat model of MCAO/R. Neural Regeneration Research, 5, 411-416.

[4]   Tayebjee, M.H., Nadar, S., Blann, A.D., Gareth Beevers, D., MacFadyen, R.J. and Lip, G.Y. (2004) Matrix metalloproteinase-9 and tissue inhibitor of metalloproteinase-1 in hypertension and their relationship to cardiovascular risk and treatment: A substudy of the Anglo-Scandinavian Cardiac Outcomes Trial (ASCOT). American Journal of Hypertension, 17, 764-769. http://dx.doi.org/10.1016/S0895-7061(04)00855-6

[5]   Gu, Z., Cui, J., Brown, S., Fridman, R., Mobashery, S., Strongin, A.Y. and Lipton, SA. (2005) A highly specific inhibitor of matrix metalloproteinase-9 rescues laminin from proteolysis and neurons from apoptosis in transient focal cerebral ischemia. Journal of Neuroscience, 25, 6401-6408. http://dx.doi.org/10.1523/JNEUROSCI.1563-05.2005

[6]   Yang, Y., Estrada, E.Y., Thompson, J.F., Liu, W. and Rosenberg, G.A. (2007) Matrix metalloproteinase mediated disruption of tight junction proteins in cerebral vessels is reversed by synthetic matrix metalloproteinase inhibitor in focal ischemia in rat. Journal of Cerebral Blood Flow & Metabolism, 27, 697-709.

[7]   Li, X., Xu, X.Y., Li, Z., Guo, Y.L. and Li, Q. (2010) Picroside II down-regulates matrix metalloproteinase-9 expression following cerebral ischemia/reperfusion injury in rats. Neural Regeneration Research, 5, 1403-1407. http://dx.doi.org/10.3969/j.issn.1673-5374.2010.18.007

[8]   Kim, S.S., Kong, P.J., Kim, B.S., Sheen, D.H., Nam, S.Y. and Chun, W. (2004) Inhibitory action of minocycline on lipopolysaccharide-induced release of nitric oxide and prostaglandin E2 in BV2 microglial cells. Archives of Pharmacal Research, 27, 314-318. http://dx.doi.org/10.1007/BF02980066

[9]   Luo, Y.M., Qin, Z. and Chen, J. (2001) Protective effects of COX2 gene knockout on brain from ischemic injury in mice. Chinese Journal of Geriatric Cardiovascular and Cerebrovascular Diseases, 3, 338-340. http://dx.doi.org/10.3969/j.issn.1009-0126.2001.05.015

[10]   Li, Z., Li, Q., Shen, W. and Guo, Y.L. (2010) The interferring effects of picroside II on the expressions of NF-κB and I-κB following cerebral ischemia reperfusion injury in rats. Chinese Pharmacological Bulletin, 26, 52-55.

[11]   Guo, Y.L., Shen, W., Du, F., et al. (2010) Effect of picroside II on expressions of TLR4 and NFKB in rats with cerebral ischemia reperfusion injury. Chinese Journal of Integrated Traditional and Western Medicine, 31, 58-61.

[12]   Li, Z., Li, Q., Guo, Y.L., Qin, L.H. and Luan, L.J. (2010) Intervention effects of picrosideⅡ in cerebral ischemic injury rats. Acta Anthropologica Sinica, 41, 9-12.

[13]   Li, Q., Guo, Y.-L., Li, Z. and Xu, X.Y. (2010) The interference of picrosideⅡ on the expressions of Caspase-3 and PARP following cerebral ischemia reperfusion injury in rats. Chinese Pharmacological Bulletin, 26, 342-345.

[14]   Li, H.-Y., Zhao, L., Su, X., Pei, H.T., Zhang, M.Z., Xin, H. and Guo, Y.L. (2010) Primary study on the best therapeutic dose and time window of picrosideⅡ in cerebral ischemic injury in rats. Chinese Pharmacological Bulletin, 28, 549-553.

[15]   Pei, H.T., Su, X., Zhao, L., Li, H.Y., Guo, Y.L., Zhang, M.Z. and Xin, H. (2012) Primary study for the therapeutic dose and time window of picroside II in treating cerebral ischemic injury in rats. International Journal of Molecular Sciences, 13, 2551-2562. http://dx.doi.org/10.3390/ijms13032551

[16]   Márquez-Martín, A., Jiménez-Altayó, F., Dantas, A.P., Caracuel, L., Planas, A.M. and Vila, E. (2012) Middle cerebral artery alterations in a rat chronic hypoperfusion model. Journal of Applied Physiology, 112, 511-518. http://dx.doi.org/10.1152/japplphysiol.00998.2011

[17]   Masato, Y. (2009) Regulation, structure and function of brain aquaporin. Rinsho Shinkeigaku, 49, 786-788. http://dx.doi.org/10.5692/clinicalneurol.49.786

[18]   Yang, M., Gao, F., Liu, H., Yu, W.H., He, G.Q., Zhuo, F., Qiu, G.P. and Sun, S.Q. (2011) Immunolocalization of aquaporins in rat brain. Anatomia, Histologia, Embryologia, 40, 299-306. http://dx.doi.org/10.1111/j.1439-0264.2011.01070.x

[19]   Yasui, M. (2011) Aquaporin from basic to clinical medicine: roles in brain edema. No To Hattatsu, 43, 191-194.

[20]   Shi, W.Z., Zhao, C.Z., Zhao, B., Zheng, X.L., Fang, S.H., Lu, Y.B., Zhang, W.P., Chen, Z. and Wei, E.Q. (2012) Aquaporin-4 deficiency attenuates acute lesions but aggravates delayed lesions and microgliosis after cryoinjury to mouse brain. Neuroscience Bulletin, 28, 61-68. http://dx.doi.org/10.1007/s12264-012-1063-7

[21]   Rosenberg, G.A., Cunningham, L.A., Wallace, J., Alexander, S., Estrada, E.Y., Grossetete, M., Razhagi, A., Miller, K. and Gearing, A. (2001) Immunohistochemistry of matrix metalloproteinases in reperfusion injury to rat brain: Activation of MMP-9 linked to stromelysin-1 and microglia in cell cultures. Brain Research, 893, 104-112. http://dx.doi.org/10.1016/S0006-8993(00)03294-7

[22]   Mehta, S.L., Manhas, N. and Raghubir, R. (2007) Molecular targets in cerebral ischemia for developing novel therapeutics. Brain Research Reviews, 54, 34-66.

[23]   Guo, Y.L., Xu, X.Y., Li, Q., et al. (2010) Anti-inflammation effects of picrosideⅡ in cerebral ischemic injury rats. Behavioral Brain Function, 6, 43-53. http://dx.doi.org/10.1186/1744-9081-6-43